efficacy
Scientists from around the world who have conducted and reviewed independent research on pelvic mesh agree it is an important treatment option for women.

We consistently evaluate our products in the clinical setting.

Continued

clinical studies

Even though Ethicon no longer sells GYNECARE PROLIFT®, clinical studies continue to report on the safety and efficacy of the procedure.

Preferred option

for millions

seeking to improve their quality of life

Surgery with implantable mesh is backed by years of clinical research, has undergone rigorous regulatory reviews and has been the preferred option for millions of women seeking to improve their quality of life.

Most important advancement in
the treatment of SUI in the last

50 years

“[the polypropylene midurethral sling] procedure is probably the most important advancement in the treatment of stress urinary incontinence in the last 50 years and has the full support of our organizations which are dedicated to improving the lives of women with urinary incontinence.”

According to a February 2018 position statement supported by the American Urogynecologic Society, the Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction, the International Urogynecological Association, the American Association of Gynecological Laparoscopists, the American College of Obstetricians and Gynecologists, the Society of Gynecologic Surgeons, and the National Association for Continence

TVT is a

highly effective

and safe option for the treatment of SUI

“The 17-year results of this study showed that TVT™ is a highly effective and safe option for the treatment of SUI."

British Medical Journal, 2018

SCENIHR supports

continuing

synthetic sling use for SUI

“However, synthetic sling SUI surgery is an accepted procedure with proven efficacy and safety in the majority of patients with moderate to severe SUI, when used by an experienced and appropriately trained surgeon. Therefore, the SCENIHR supports continuing synthetic sling use for SUI, but emphasizes the importance of appropriately trained surgeons and detailed counselling of patients about the associated risk/benefits."

EU Scientific Committee On Emerging And Newly Identified Health Risks
December 2015 | SOURCE

Use of mesh to treat women with SUI and POP

is a safe option

for women

“The use of mesh to treat women with SUI and POP is a safe option for women.”

“For many women suffering the distressing effects of SUI and POP, surgical procedures using mesh devices have provided an effective form of treatment which can be far less invasive than alternative surgical procedures."

NHS England Mesh Oversight Group July 2017 | SOURCE

women must be offered all

appropriate
treatments

(mesh and nonmesh)

“In the case of surgical treatment for SUI, a review of the different sources of evidence has led us to recommend that women must be offered all appropriate treatments (mesh and nonmesh) as well as the information to make informed choices."

Scottish Government Independent Review Group March 2017 | SOURCE

the most extensively researched

surgical treatment

for SUI

“Mid-urethral sling operations have been the most extensively researched surgical treatment for stress urinary incontinence (SUI) in women and have a good safety profile. Irrespective of the routes traversed, they are highly effective in the short and medium term, and accruing evidence demonstrates their effectiveness in the long term."

Cochrane July 2015 | SOURCE

evidence supports the use of
these devices in

the UK

“What we continue to see is that evidence supports the use of these devices in the UK for treatment of the distressing conditions of incontinence and organ prolapse in appropriate circumstances. This is supported by the greater proportion of the clinical community and patients."

UK Medicines and Healthcare Products Regulatory Agency
October 2017 | SOURCE

No other surgical treatment for SUI before
or since has been subject to such

extensive
investigation

"Among historical SUI procedures, the midurethral sling has been studied as long in follow-up after implantation as any other procedure and has demonstrated superior safety and efficacy. No other surgical treatment for SUI before or since has been subject to such extensive investigation.”

Joint Statement by numerous organizations, including the American Urogynecologic Society, the Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction, the American College of Obstetricians and Gynecologists, the International Urogynecological Association, the Society of Gynecologic Surgeons, and the American Association of Gynecological Laparoscopists February 2018 | SOURCE

The polypropylene midurethral sling has helped

millions of women

with SUI regain control of their lives

“The polypropylene midurethral sling has helped millions of women with SUI regain control of their lives by undergoing a simple outpatient procedure that allows them to return to daily life very quickly. With its acknowledged safety and efficacy it has created an environment for a much larger number of women to have access to treatment.” 

The American Urogynecologic Society and the Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction 2014 position statement | SOURCE